NCT05878535 - METFORMIN FOR ATRIAL FIBRILLATION | Biotech Hunter

Enrollment

770

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

April 30, 2025

Conditions

Atrial Fibrillation

Interventions

DRUG

Metformin

Metformin 850 mg oral tablets. Prescribed: Once daily PO with meals and 200 mL of water. The dose can be up-titrated to 1500-2000 mg divided q8-12hr with meals in enrolled diabetic patients as a monotherapy or combined with sulfonylurea.

DRUG

Placebo

Placebo oral tablets. Prescribed: Once daily PO with meals and 200 mL of water.

Trial Locations (1)

Unknown

Arab Contractors Medical Centre, Cairo

All Listed Sponsors

lead

Arab Contractors Medical Centre

OTHER